Stanford University
Showing 351-360 of 457 Results
-
Adam Nielander
Staff Scientist, SLAC National Accelerator Laboratory
BioMy research focuses in the areas electrocatalysis, electrolysis, and solar-driven chemical fuel production. We develop catalysts, instrumentation, methodologies, and device engineering/designs for improved production of chemical fuels (e.g., H2, NH3, ethanol) from abundant feedstocks (e.g., H2O, N2, CO2). This work includes in situ and operando studies of catalyst/ionomer interfaces under operating conditions and is underpinned by complementary driving aims to develop next-generation electrochemical technologies and to elucidate the fundamental principles that dictate the performance of sustainably-driven electrochemical processes.
-
Erik Nielsen
Marketing Specialist, Office of Technology Licensing (OTL)
Marketing Specialist, Stanford Office of Technology LicensingBioErik Nielsen (he/him) is a Marketing Specialist on the Business Development and Marketing Team (BDM) at Stanford's Office of Technology Licensing (OTL). He updates and maintains marketing contact and company data, manages preliminary technical marketing tasks, including liaising with inventors, manages the email push campaigns and Techfinder website marketing of Stanford technologies (generally of the Life Sciences), and helps track marketing outreach response. He also assists with special projects as needed, including website content layout, updates, and maintenance. He's worked for Stanford's OTL since early 2018.
Education:
B.A. Psychology, UC Davis -
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology.
